RxDoctor Payments Data

Leah Macaulay, APRN

Psychiatric/Mental Health · Maryville, TNNPI 1184499733

Payments from drug & device makers

$3,890in general payments, 2019–2025

Across 241 payments — averaging $16.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$562
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$468
  • Alkermes, Inc.$431
  • Neurocrine Biosciences, Inc.$406
  • Supernus Pharmaceuticals, Inc.$387
  • Johnson & Johnson$312
  • plus $1K from 7 others

What the payments were for

  • Food & beverage$3,84399%
  • Education$471%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,890 in reported general payments places this provider in the 85th percentile of 1,167 psychiatric/mental health providers in Tennessee.

See all psychiatric/mental health providers in Tennessee

Medicare billing

Part B allowed, 2024
$4,845
Medicare patients
30
Services billed
57

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate30$109,710
Abilify MaintenaAripiprazole25$77,431
RexultiBrexpiprazole23$35,562
VraylarCariprazine Hcl17$26,367
CaplytaLumateperone Tosylate11$18,224
Lurasidone Hcl16$3,948
Aripiprazole46$2,407
Trazodone Hcl94$2,138
Quetiapine Fumarate92$1,602
Oxcarbazepine40$1,588
Buspirone Hcl76$1,519
Vilazodone Hcl12$1,248
Bupropion XlBupropion Hcl46$1,181
Divalproex Sodium ErDivalproex Sodium12$1,110
Hydroxyzine Hcl46$1,104

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$562$112,99448 claims
Johnson & JohnsonInvega Sustenna$312$109,71030 claims
AbbVieVraylar$209$26,36717 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$468$18,22411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,167 psychiatric/mental health providers in Tennessee.

Other psychiatric/mental health in Maryville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →